|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
PerkinElmer, Inc. (PKI) Announces Financial Results for the Third Quarter of 2012
10/26/2012 7:38:50 AM
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today reported financial results for the third quarter ended September 30, 2012.
The Company reported GAAP earnings per share from continuing operations of $0.25, compared to $0.25 in the third quarter of 2011. Revenue in the third quarter of 2012 was $509.6 million, as compared to $452.9 million in the third quarter of 2011. GAAP operating income from continuing operations for the third quarter of 2012 increased 20% to $43.2 million, compared to $36.1 million in the third quarter of 2011. GAAP operating profit margin from continuing operations was 8% in the third quarter of 2012, compared to 8% in the third quarter of 2011.
|
|
|
|
|
|
|
|
|
|
|